Categories
-
Wal-Mart
- General Motors
- Dow Jones
- Goldman Sachs
- Accor
- Renault
- Reuters
- BNP Paribas
- Toyota
- AgBank
- Microsoft
- Intel
- ALCATEL-LUCENT
- AXA
- Japan Airlines
- Agricultural Bank of China
- Lucien Barri
- CITIGROUP
- toutes nos catégories
Tags
NICE Appraisal Of Dasatinib And Nilotinib For Chronic Myeloid LeukaemiaThe National Institute for Health and Clinical Excellence (NICE) is currently appraising the use of dasatinib (made by Bristol Myers-Squibb) and nilotinib (Novartis) for chronic myeloid leukaemia in patients whose treatment with imatinib has failed due to resistance and/or intolerance. As with all NICE appraisals, an independent committee of experts and lay people considered evidence presented ...
2010-01-06 - Medical News Today